Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial
SARS-CoV-2重组蛋白纳米颗粒疫苗GBP510佐剂AS03的免疫原性和安全性:一项随机、活性对照、观察者盲法3期临床试验的中期结果
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2023.102140
Song, Joon Young; Choi, Won Suk; Heo, Jung Yeon; Kim, Eun Jin; Lee, Jin Soo; Jung, Dong Sik; Kim, Shin-Woo; Park, Kyung-Hwa; Eom, Joong Sik; Jeong, Su Jin; Lee, Jacob; Kwon, Ki Tae; Choi, Hee Jung; Sohn, Jang Wook; Kim, Young Keun; Yoo, Byung Wook; Jang, In-Jin; Capeding, Maria Z; Roman, François; Breuer, Thomas; Wysocki, Piotr; Carter, Lauren; Sahastrabuddhe, Sushant; Song, Manki; D'Cor, Naveena; Kim, Hun; Ryu, Ji Hwa; Lee, Su Jeen; Park, Yong Wook; Cheong, Hee Jin